|
|
Article: Epigenomics AG Announces End of IPO Lock-Up Period.
- Article from:
- PR Newswire
- Article date:
- January 20, 2005
|
Copyright informationCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Original VC Investors Indicate Continued Support of Company
Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it has been informed by the majority of its venture capital investors:
- DVC (DVCG mbH & Co Fonds II KG, Venture Capital mbH & Co Fonds III),
- MPM (MPM Bioventures GmbH & Co; MPM Bioventures II-QP, LP; MPM
Bioventures II, LP; MPM Asset Management Investors 2000 BLLC),
- 3i (Technologie Holding Fonds VC GmbH; 3i Group Investments LPM;
Technologieholding Fonds NBL GmbH),
- Strategic European Technologies NV,
- Abingworth (Abingworth ...
Related newspaper, magazine, and journal articles:
|
|
Article: Role of venture capital sector, BUSINESS TIMES
Business Times (Malaysia);
September 8, 2000 ;
700+ words
......Malaysia) 09-08-2000 UNTIL recently, venture capital was a relatively unknown concept in...because the context in which the term "venture capital" is used in Asia is often different...also abundant, hitherto unavailable, venture capital and other funds, meant that it was...
|
|